JPMorgan Chase Financial Co. LLC Files 424B2 Prospectus

TL;DR

**JPM Financial Co. just filed a prospectus for new securities.**

AI Summary

This 424B2 filing, submitted on March 24, 2026, by JPMorgan Chase Financial Co. LLC, is a prospectus related to a securities offering. It indicates that JPMorgan Chase & Co. is also involved as a filer. This matters to investors because it signals that JPMorgan Chase Financial Co. LLC is actively raising capital, which could be for various purposes like funding operations, investments, or debt repayment, potentially impacting the company's financial structure and future performance.

Why It Matters

This filing indicates JPMorgan Chase Financial Co. LLC is offering new securities, which could dilute existing shares or provide capital for growth, directly impacting shareholder value.

Risk Assessment

Risk Level: medium — The filing itself is administrative, but the underlying offering of securities can introduce market risk, dilution risk, or interest rate risk depending on the security type.

Analyst Insight

Investors should look for the full prospectus details to understand the type of securities being offered, their terms, and the intended use of proceeds, as this will determine the impact on JPMorgan Chase Financial Co. LLC and potentially JPMorgan Chase & Co.

Key Players & Entities

• JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus
• JPMorgan Chase & Co (company) — Related filer with CIK 0000019617
• 0001665650 (person) — CIK for JPMorgan Chase Financial Co. LLC
• 0000019617 (person) — CIK for JPMorgan Chase & Co
• 2026-03-24 (date) — Filing date of the 424B2

FAQ

Key Financial Figures

• $756,000 — l Company LLC Structured Investments $756,000 Auto Callable Contingent Interest Not
• $1,000 — f the notes. Minimum denominations of $1,000 and integral multiples thereof The no
• $42.75 — roceeds to Issuer Per note $1,000 $42.75 $957.25 Total $756,000 $32,319
• $957.25 — o Issuer Per note $1,000 $42.75 $957.25 Total $756,000 $32,319 $723,681
• $32,319 — $42.75 $957.25 Total $756,000 $32,319 $723,681 (1) See "Supplemental Use
• $723,681 — $957.25 Total $756,000 $32,319 $723,681 (1) See "Supplemental Use of Proceeds
• $901.90 — en the terms of the notes were set, was $901.90 per $1,000 principal amount note. See "
• $8.9167 — a Contingent Interest Payment equal to $8.9167 (equivalent to a Contingent Interest Ra
• $535.0000 — tal Contingent Interest Payments 60 $535.0000 59 $526.0833 58 $517.1667 57
• $526.0833 — terest Payments 60 $535.0000 59 $526.0833 58 $517.1667 57 $508.2500 56
• $517.1667 — 60 $535.0000 59 $526.0833 58 $517.1667 57 $508.2500 56 $499.3333 55
• $508.2500 — 59 $526.0833 58 $517.1667 57 $508.2500 56 $499.3333 55 $490.4167 54
• $499.3333 — 58 $517.1667 57 $508.2500 56 $499.3333 55 $490.4167 54 $481.5000 53
• $490.4167 — 57 $508.2500 56 $499.3333 55 $490.4167 54 $481.5000 53 $472.5833 52
• $481.5000 — 56 $499.3333 55 $490.4167 54 $481.5000 53 $472.5833 52 $463.6667 51

Filing Documents

• form424b2.htm (424B2) — 257KB
• exfilingfees.htm (EX-FILING FEES) — 5KB
• image_001.jpg (GRAPHIC) — 21KB
• image_002.jpg (GRAPHIC) — 5KB
• image_006.jpg (GRAPHIC) — 177KB
• image_003.gif (GRAPHIC) — 5KB
• image_004.gif (GRAPHIC) — 5KB
• image_005.gif (GRAPHIC) — 5KB
• 0001918704-26-007934.txt ( ) — 650KB
• exfilingfees_htm.xml (XML) — 2KB

From the Filing

SUPPLEMENT March 20, 2026 Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(2) JPMorgan Chase Financial Company LLC Structured Investments $756,000 Auto Callable Contingent Interest Notes Linked to the MerQube US Large-Cap Vol Advantage Index due March 25, 2031 Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. The notes are designed for investors who seek a Contingent Interest Payment with respect to each monthly Interest Review Date for which the closing level of the MerQube US Large-Cap Vol Advantage Index, which we refer to as the Index, is greater than or equal to 60.00% of the Initial Value, which we refer to as the Interest Barrier. If the closing level of the Index is greater than or equal to the Interest Barrier on any Interest Review Date, investors will receive, in addition to the Contingent Interest Payment with respect to that Interest Review Date, any previously unpaid Contingent Interest Payments for prior Interest Review Dates. The notes will be automatically called if the closing level of the Index on any quarterly Autocall Review Date is greater than or equal to the Initial Value. The earliest date on which an automatic call may be initiated is March 22, 2027. Investors should be willing to accept the risk of losing a significant portion or all of their principal and the risk that no Contingent Interest Payment may be made with respect to some or all Interest Review Dates. Investors should also be willing to forgo fixed interest and dividend payments, in exchange for the opportunity to receive Contingent Interest Payments. The Index is subject to a 6.0% per annum daily deduction. This daily deduction will offset any appreciation of the futures contracts included in the Index, will heighten any depreciation of those futures contracts and will generally be a drag on the performance of the Index. The Index will trail the performance of an identical index without a deduction. See "Selected Risk Considerations — Risks Relating to the Notes Generally — The Level of the Index Will Include a 6.0% per Annum Daily Deduction" in this pricing supplement. The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. Minimum denominations of $1,000 and integral multiples thereof The notes priced on March 20, 2026 and are expected to settle on or about March 25, 2026. CUSIP: 46660RC93 Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" beginning on page PS-11 of the accompanying product supplement, "Risk Factors" beginning on page US-4 of the accompanying underlying supplement and "Selected Risk Considerations" beginning on page PS-8 of this pricing supplement. Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense. Price to Public (1) Fees and Commissions (2) Proceeds to Issuer Per note $1,000 $42.75 $957.25 Total $756,000 $32,319 $723,681 (1) See "Supplemental Use of Proceeds" in this pricing supplement for information about the components of the price to public of the notes. (2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of $42.75 per $1,000 principal amount note it receives from us to other affiliated or unaffiliated dealers. See "Plan of Distribution (Conflicts of Interest)" in the accompanying product supplement. The estimated value of the notes, when the terms of the notes were set, was $901.90 per $1,000 principal amount note. See "The Estimated Value of the Notes" in this pricing supplement for additional information. The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank. Pricing supplement to product supplement no. 4-I dated April 13, 2023, underlying supplement no. 5-III dated March 5, 2025, the prospectus and prospectus supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024 Key Terms Issuer: JPMorgan Chase Financial Company LLC, a direct, wholly owned finance subsidiary of JPMorgan Chase & Co. Guarantor: JPMorgan Chase & Co. Index: The MerQube US

View Full Filing

View this 424B2 filing on SEC EDGAR